{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T21:04:43Z","timestamp":1760821483896,"version":"3.43.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CHEST"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.chest.2024.11.014","type":"journal-article","created":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T02:53:24Z","timestamp":1732157604000},"page":"1705-1713","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evolution of Diffusing Capacity of the Lungs for Carbon Monoxide in Lymphangioleiomyomatosis"],"prefix":"10.1016","volume":"167","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5344-9731","authenticated-orcid":false,"given":"Bennett E.","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2376-6370","authenticated-orcid":false,"given":"Jason M.","family":"Elinoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7169-5693","authenticated-orcid":false,"given":"Adrienne E.","family":"Campbell-Washburn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6844-2997","authenticated-orcid":false,"given":"Han","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel","family":"Moss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.chest.2024.11.014_bib1","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1086\/301804","article-title":"Evidence that lymphangiomyomatosis is caused by TSC2 mutations: chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangiomyomatosis","volume":"62","author":"Smolarek","year":"1998","journal-title":"Am J Hum Genet"},{"issue":"3","key":"10.1016\/j.chest.2024.11.014_bib2","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ccm.2016.04.002","article-title":"Lymphangioleiomyomatosis","volume":"37","author":"Johnson","year":"2016","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.chest.2024.11.014_bib3","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1749-6632.1991.tb37754.x","article-title":"Epidemiology of tuberous sclerosis","volume":"615","author":"Osborne","year":"1991","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"10.1016\/j.chest.2024.11.014_bib4","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1164\/rccm.202310-1736LE","article-title":"Updated prevalence of lymphangioleiomyomatosis in Europe","volume":"209","author":"Lynn","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.chest.2024.11.014_bib5","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1164\/rccm.202312-2254ED","article-title":"Lymphangioleiomyomatosis: no longer ultra-rare","volume":"209","author":"Gupta","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.chest.2024.11.014_bib6","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0046-8177(97)90061-7","article-title":"Immunohistochemical study of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in pulmonary lymphangioleiomyomatosis (LAM)","volume":"28","author":"Hayashi","year":"1997","journal-title":"Hum Pathol"},{"issue":"2","key":"10.1016\/j.chest.2024.11.014_bib7","doi-asserted-by":"crossref","first-page":"267","DOI":"10.5858\/2000-124-0267-RFAOMM","article-title":"Role for activation of matrix metalloproteinases in the pathogenesis of pulmonary lymphangioleiomyomatosis","volume":"124","author":"Matsui","year":"2000","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"10.1016\/j.chest.2024.11.014_bib8","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1378\/chest.07-0898","article-title":"Lymphangioleiomyomatosis: a clinical update","volume":"133","author":"McCormack","year":"2008","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.chest.2024.11.014_bib9","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1177\/107327480601300405","article-title":"Lymphangioleiomyomatosis","volume":"13","author":"Taveira-DaSilva","year":"2006","journal-title":"Cancer Control"},{"issue":"2","key":"10.1016\/j.chest.2024.11.014_bib10","first-page":"348","article-title":"Pulmonary lymphangiomyomatosis. A review","volume":"79","author":"Corrin","year":"1975","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.chest.2024.11.014_bib11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00408-012-9419-3","article-title":"Clinical predictors of mortality and cause of death in lymphangioleiomyomatosis: a population-based registry","volume":"191","author":"Oprescu","year":"2013","journal-title":"Lung"},{"issue":"6","key":"10.1016\/j.chest.2024.11.014_bib12","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1164\/rccm.201607-1384ST","article-title":"Official American Thoracic Society\/Japanese Respiratory Society clinical practice guidelines: lymphangioleiomyomatosis diagnosis and management","volume":"194","author":"McCormack","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1016\/j.chest.2024.11.014_bib13","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1097\/00000478-199311000-00002","article-title":"Transbronchial biopsy in lymphangiomyomatosis of the lung. HMB45 for diagnosis","volume":"17","author":"Bonetti","year":"1993","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.chest.2024.11.014_bib14","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/ajcp\/96.4.529","article-title":"Estrogen and progesterone receptors in lymphangioleiomyomatosis, epithelioid hemangioendothelioma, and sclerosing hemangioma of the lung","volume":"96","author":"Ohori","year":"1991","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"10.1016\/j.chest.2024.11.014_bib15","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1378\/chest.126.6.1867","article-title":"Decline in lung function in patients with lymphangioleiomyomatosis treated with or without progesterone","volume":"126","author":"Taveira-DaSilva","year":"2004","journal-title":"Chest"},{"issue":"2 pt 1","key":"10.1016\/j.chest.2024.11.014_bib16","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1164\/ajrccm.151.2.7842216","article-title":"Pulmonary lymphangioleiomyomatosis: a report of 46 patients including a clinicopathologic study of prognostic factors","volume":"151","author":"Kitaichi","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.chest.2024.11.014_bib17","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1164\/ajrccm\/144.4.892","article-title":"Quantitative assessment of lung pathology in idiopathic pulmonary fibrosis. The BAL Cooperative Group Steering Committee","volume":"144","author":"Cherniack","year":"1991","journal-title":"Am Rev Respir Dis"},{"issue":"4","key":"10.1016\/j.chest.2024.11.014_bib18","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/00000478-200104000-00007","article-title":"Prognostic significance of pulmonary lymphangioleiomyomatosis histologic score","volume":"25","author":"Matsui","year":"2001","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.chest.2024.11.014_bib19","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1164\/ajrccm.164.6.2102125","article-title":"Reversible airflow obstruction, proliferation of abnormal smooth muscle cells, and impairment of gas exchange as predictors of outcome in lymphangioleiomyomatosis","volume":"164","author":"Taveira-DaSilva","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1016\/j.chest.2024.11.014_bib20","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1164\/rccm.200206-593OC","article-title":"Maximal oxygen uptake and severity of disease in lymphangioleiomyomatosis","volume":"168","author":"Taveira-DaSilva","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.chest.2024.11.014_bib21","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1164\/rccm.201203-0372OC","article-title":"Exercise performance and dynamic hyperinflation in lymphangioleiomyomatosis","volume":"186","author":"Baldi","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"4 pt 1","key":"10.1016\/j.chest.2024.11.014_bib22","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1164\/ajrccm.153.4.8616568","article-title":"Lymphangioleiomyomatosis: the pathophysiology of diminished exercise capacity","volume":"153","author":"Crausman","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.chest.2024.11.014_bib23","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1148\/radiology.175.2.2326457","article-title":"Pulmonary lymphangiomyomatosis: correlation of CT with radiographic and functional findings","volume":"175","author":"Muller","year":"1990","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.chest.2024.11.014_bib24","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1148\/radiology.214.2.r00fe41441","article-title":"Pulmonary lymphangioleiomyomatosis: correlation of ventilation-perfusion scintigraphy, chest radiography, and CT with pulmonary function tests","volume":"214","author":"Avila","year":"2000","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.chest.2024.11.014_bib25","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1148\/radiol.2231010315","article-title":"Lymphangioleiomyomatosis: correlation of qualitative and quantitative thin-section CT with pulmonary function tests and assessment of dependence on pleurodesis","volume":"223","author":"Avila","year":"2002","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.chest.2024.11.014_bib26","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1148\/radiology.176.2.2367651","article-title":"Lymphangiomyomatosis: CT, chest radiographic, and functional correlations","volume":"176","author":"Aberle","year":"1990","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.chest.2024.11.014_bib27","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1378\/chest.109.1.131","article-title":"Quantitative CT predicts the severity of physiologic dysfunction in patients with lymphangioleiomyomatosis","volume":"109","author":"Crausman","year":"1996","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.chest.2024.11.014_bib28","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.2214\/AJR.07.3334","article-title":"Automated algorithm for quantifying the extent of cystic change on volumetric chest CT: initial results in lymphangioleiomyomatosis","volume":"192","author":"Schmithorst","year":"2009","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"10.1016\/j.chest.2024.11.014_bib29","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1164\/rccm.200204-347OC","article-title":"Repeatability of spirometry in 18,000 adult patients","volume":"169","author":"Enright","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.chest.2024.11.014_bib30","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1164\/rccm.200409-1298OC","article-title":"The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment","volume":"173","author":"Ryu","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.chest.2024.11.014_bib31","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1378\/chest.09-0624","article-title":"Reversible airflow obstruction in lymphangioleiomyomatosis","volume":"136","author":"Taveira-DaSilva","year":"2009","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.chest.2024.11.014_bib32","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.chest.2018.06.016","article-title":"The NHLBI LAM Registry: prognostic physiologic and radiologic biomarkers emerge from a 15-year prospective longitudinal analysis","volume":"155","author":"Gupta","year":"2019","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.chest.2024.11.014_bib33","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1136\/thoraxjnl-2019-213338","article-title":"Cross-sectional study of reversible airway obstruction in LAM: better evidence is needed for bronchodilator and inhaled steroid use","volume":"74","author":"Johnson","year":"2019","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.chest.2024.11.014_bib34","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02066-2018","article-title":"Analysis of the MILES cohort reveals determinants of disease progression and treatment response in lymphangioleiomyomatosis","volume":"53","author":"Gupta","year":"2019","journal-title":"Eur Respir J"},{"issue":"17","key":"10.1016\/j.chest.2024.11.014_bib35","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1056\/NEJMoa1100391","article-title":"Efficacy and safety of sirolimus in lymphangioleiomyomatosis","volume":"364","author":"McCormack","year":"2011","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.chest.2024.11.014_bib36","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1056\/NEJMc0707517","article-title":"Diagnostic potential of serum VEGF-D for lymphangioleiomyomatosis","volume":"358","author":"Young","year":"2008","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.chest.2024.11.014_bib37","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1089\/lrb.2006.4.143","article-title":"Vascular endothelial growth factor-D is increased in serum of patients with lymphangioleiomyomatosis","volume":"4","author":"Seyama","year":"2006","journal-title":"Lymphat Res Biol"},{"issue":"11","key":"10.1016\/j.chest.2024.11.014_bib38","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1164\/rccm.201405-0918OC","article-title":"Sustained effects of sirolimus on lung function and cystic lung lesions in lymphangioleiomyomatosis","volume":"190","author":"Yao","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.chest.2024.11.014_bib39","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.chest.2017.05.012","article-title":"Long-term effect of sirolimus on serum vascular endothelial growth factor D levels in patients with lymphangioleiomyomatosis","volume":"153","author":"Taveira-DaSilva","year":"2018","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.chest.2024.11.014_bib40","doi-asserted-by":"crossref","first-page":"797","DOI":"10.7326\/0003-4819-154-12-201106210-00007","article-title":"Changes in lung function and chylous effusions in patients with lymphangioleiomyomatosis treated with sirolimus","volume":"154","author":"Taveira-DaSilva","year":"2011","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.chest.2024.11.014_bib41","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s00330-019-06412-4","article-title":"Effects of sirolimus in lymphangioleiomyomatosis patients on lung cysts and pulmonary function: long-term follow-up observational study","volume":"30","author":"Kim","year":"2020","journal-title":"Eur Radiol"},{"issue":"2","key":"10.1016\/j.chest.2024.11.014_bib42","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa063564","article-title":"Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis","volume":"358","author":"Bissler","year":"2008","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.chest.2024.11.014_bib43","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.chest.2022.05.036","article-title":"Impact of age, menopause, and sirolimus on spontaneous pneumothoraces in lymphangioleiomyomatosis","volume":"162","author":"Cortinas","year":"2022","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.chest.2024.11.014_bib44","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S2213-2600(13)70090-0","article-title":"Serum VEGF-D a concentration as a biomarker of lymphangioleiomyomatosis severity and treatment response: a prospective analysis of the Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus (MILES) trial","volume":"1","author":"Young","year":"2013","journal-title":"Lancet Respir Med"},{"issue":"2","key":"10.1016\/j.chest.2024.11.014_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212776","article-title":"Serum vascular endothelial growth factor-D as a diagnostic and therapeutic biomarker for lymphangioleiomyomatosis","volume":"14","author":"Hirose","year":"2019","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.chest.2024.11.014_bib46","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00408-018-00191-3","article-title":"Concentration of serum vascular endothelial growth factor (VEGF-D) and its correlation with functional and clinical parameters in patients with lymphangioleiomyomatosis from a Brazilian reference center","volume":"197","author":"Amaral","year":"2019","journal-title":"Lung"},{"issue":"1","key":"10.1016\/j.chest.2024.11.014_bib47","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.chest.2023.02.026","article-title":"Determinants of progression and mortality in lymphangioleiomyomatosis","volume":"164","author":"Xu","year":"2023","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.chest.2024.11.014_bib48","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1440-1843.2007.01101.x","article-title":"The epidemiology of lymphangioleiomyomatosis in Japan: a nationwide cross-sectional study of presenting features and prognostic factors","volume":"12","author":"Hayashida","year":"2007","journal-title":"Respirology"},{"issue":"4","key":"10.1016\/j.chest.2024.11.014_bib49","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1046\/j.1440-1843.2001.00343.x","article-title":"Longitudinal follow-up study of 11 patients with pulmonary lymphangioleiomyomatosis: diverse clinical courses of LAM allow some patients to be treated without anti-hormone therapy","volume":"6","author":"Seyama","year":"2001","journal-title":"Respirology"},{"issue":"4","key":"10.1016\/j.chest.2024.11.014_bib50","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02258-2017","article-title":"Rates of change in FEV1 and Dlco as potential indicators for mTOR inhibitor therapy in premenopausal lymphangioleiomyomatosis patients","volume":"51","author":"Taveira-DaSilva","year":"2018","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.chest.2024.11.014_bib51","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1136\/thoraxjnl-2021-217809","article-title":"Disease monitoring using lung function trajectory in lymphangioleiomyomatosis: assessment in two national cohorts","volume":"78","author":"Johnson","year":"2023","journal-title":"Thorax"},{"key":"10.1016\/j.chest.2024.11.014_bib52","unstructured":"Multicenter Interventional Lymphangioleiomyomatosis (LAM) Early Disease Trial (MILED). ClinicalTrials.gov. identifier: NCT03150914. Updated December 24, 2024. Accessed March 14, 2025. http:\/\/clinicaltrials.gov\/ct2\/show\/NCT03150914"},{"issue":"1","key":"10.1016\/j.chest.2024.11.014_bib53","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s13023-018-0946-8","article-title":"Efficacy and safety of low-dose sirolimus in lymphangioleiomyomatosis","volume":"13","author":"Yoon","year":"2018","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"10.1016\/j.chest.2024.11.014_bib54","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1148\/rg.2017170056","article-title":"CT texture analysis: definitions, applications, biologic correlates, and challenges","volume":"37","author":"Lubner","year":"2017","journal-title":"Radiographics"},{"issue":"4","key":"10.1016\/j.chest.2024.11.014_bib55","doi-asserted-by":"crossref","first-page":"787","DOI":"10.2214\/AJR.11.7888","article-title":"CT grading of lung disease in lymphangioleiomyomatosis","volume":"199","author":"Yao","year":"2012","journal-title":"AJR Am J Roentgenol"},{"issue":"5","key":"10.1016\/j.chest.2024.11.014_bib56","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.chest.2019.01.004","article-title":"Use of CT imaging to quantify progression and response to treatment in lymphangioleiomyomatosis","volume":"155","author":"Gopalakrishnan","year":"2019","journal-title":"Chest"},{"issue":"11","key":"10.1016\/j.chest.2024.11.014_bib57","article-title":"Automated segmentation and measurements of pulmonary cysts in lymphangioleiomyomatosis across multiple CT scanner platforms over a period of two decades","volume":"10","author":"Lee","year":"2023","journal-title":"Bioengineering (Basel)"},{"issue":"14","key":"10.1016\/j.chest.2024.11.014_bib58","article-title":"Clinical trial validation of automated segmentation and scoring of pulmonary cysts in thoracic CT scans","volume":"14","author":"Baral","year":"2024","journal-title":"Diagnostics (Basel)"},{"issue":"1","key":"10.1016\/j.chest.2024.11.014_bib59","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1186\/s12890-022-02123-7","article-title":"Computer grading of lung disease severity in patients with lymphangioleiomyomatosis referred for transplantation","volume":"22","author":"Taveira-DaSilva","year":"2022","journal-title":"BMC Pulm Med"},{"issue":"3","key":"10.1016\/j.chest.2024.11.014_bib60","doi-asserted-by":"crossref","first-page":"2003769","DOI":"10.1183\/13993003.03769-2020","article-title":"Effect of non-uniform cyst distribution in lymphangioleiomyomatosis on pulmonary function: a cross-sectional study","volume":"57","author":"Hasani","year":"2021","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.chest.2024.11.014_bib61","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1007\/s00330-019-06635-5","article-title":"Physical evaluation of an ultra-high-resolution CT scanner","volume":"30","author":"Oostveen","year":"2020","journal-title":"Eur Radiol"},{"issue":"2","key":"10.1016\/j.chest.2024.11.014_bib62","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.clinimag.2019.11.004","article-title":"Clinical CT underestimation of the percentage volume occupied by cysts in patients with lymphangioleiomyomatosis","volume":"59","author":"Larsen","year":"2020","journal-title":"Clin Imaging"},{"issue":"1","key":"10.1016\/j.chest.2024.11.014_bib63","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.chest.2021.01.077","article-title":"Ultra-small lung cysts impair diffusion without obstructing air flow in lymphangioleiomyomatosis","volume":"160","author":"Matthew","year":"2021","journal-title":"Chest"},{"issue":"7","key":"10.1016\/j.chest.2024.11.014_bib64","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1513\/AnnalsATS.202212-1003RL","article-title":"Novel pulmonary cyst characteristics associated with the diffusing capacity of the lung in lymphangioleiomyomatosis: a cross-sectional study","volume":"20","author":"Matthew","year":"2023","journal-title":"Ann Am Thorac Soc"},{"issue":"12","key":"10.1016\/j.chest.2024.11.014_bib65","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1007\/s00247-016-3672-1","article-title":"Feasibility, tolerability and safety of pediatric hyperpolarized (129)Xe magnetic resonance imaging in healthy volunteers and children with cystic fibrosis","volume":"46","author":"Walkup","year":"2016","journal-title":"Pediatr Radiol"},{"issue":"2","key":"10.1016\/j.chest.2024.11.014_bib66","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jcf.2016.07.008","article-title":"Hyperpolarized (129)Xe for investigation of mild cystic fibrosis lung disease in pediatric patients","volume":"16","author":"Thomen","year":"2017","journal-title":"J Cyst Fibros"},{"issue":"8","key":"10.1016\/j.chest.2024.11.014_bib67","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1513\/AnnalsATS.201812-880OC","article-title":"Cyst ventilation heterogeneity and alveolar airspace dilation as early disease markers in lymphangioleiomyomatosis","volume":"16","author":"Walkup","year":"2019","journal-title":"Ann Am Thorac Soc"},{"issue":"11","key":"10.1016\/j.chest.2024.11.014_bib68","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/nm1196-1236","article-title":"Noninvasive assessment of regional ventilation in the human lung using oxygen-enhanced magnetic resonance imaging","volume":"2","author":"Edelman","year":"1996","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.chest.2024.11.014_bib69","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1148\/radiol.2019190452","article-title":"Opportunities in interventional and diagnostic imaging by using high-performance low-field-strength MRI","volume":"293","author":"Campbell-Washburn","year":"2019","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.chest.2024.11.014_bib70","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/RLI.0000000000000832","article-title":"Assessment of lung structure and regional function using 0.55 T MRI in patients with lymphangioleiomyomatosis","volume":"57","author":"Bhattacharya","year":"2022","journal-title":"Invest Radiol"},{"issue":"8","key":"10.1016\/j.chest.2024.11.014_bib71","doi-asserted-by":"crossref","DOI":"10.1002\/nbm.4562","article-title":"Oxygen-enhanced functional lung imaging using a contemporary 0.55 T MRI system","volume":"34","author":"Bhattacharya","year":"2021","journal-title":"NMR Biomed"},{"issue":"1","key":"10.1016\/j.chest.2024.11.014_bib72","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00016-2016","article-title":"2017 ERS\/ATS standards for single-breath carbon monoxide uptake in the lung","volume":"49","author":"Graham","year":"2017","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.chest.2024.11.014_bib73","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0245434","article-title":"Assessing the applicability of the new Global Lung Function Initiative reference values for the diffusing capacity of the lung for carbon monoxide in a large population set","volume":"16","author":"Wardyn","year":"2021","journal-title":"PLoS One"},{"author":"Yang","key":"10.1016\/j.chest.2024.11.014_bib74"}],"container-title":["CHEST"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369224055867?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369224055867?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T05:53:14Z","timestamp":1754459594000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369224055867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":74,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0012369224055867"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2024.11.014","relation":{},"ISSN":["0012-3692"],"issn-type":[{"type":"print","value":"0012-3692"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evolution of Diffusing Capacity of the Lungs for Carbon Monoxide in Lymphangioleiomyomatosis","name":"articletitle","label":"Article Title"},{"value":"CHEST","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2024.11.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc under license from the American College of Chest Physicians.","name":"copyright","label":"Copyright"}]}}